Trial Profile
A Study to Compare the Efficacy of Efavirenz versus Ritonavir-boosted Protease Inhibitor Based Initial Antiretroviral Therapy in Patients with HIV-1 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 23 Dec 2015 New trial record